180 related articles for article (PubMed ID: 28246699)
41. [Staging with 18F-FDG-PET/CT influences stage-specific survival in advanced non-small cell lung cancer (NSCLC)].
Tönnies S; Bauer TT; Misch D; Boch C; Blum T; Bittner RC; Förster GJ; Kollmeier J
Pneumologie; 2012 Apr; 66(4):212-7. PubMed ID: 22477481
[TBL] [Abstract][Full Text] [Related]
42. Prognostic impact of malignant pleural effusion at presentation in patients with metastatic non-small-cell lung cancer.
Morgensztern D; Waqar S; Subramanian J; Trinkaus K; Govindan R
J Thorac Oncol; 2012 Oct; 7(10):1485-9. PubMed ID: 22982649
[TBL] [Abstract][Full Text] [Related]
43. The applicability of the proposed IASLC staging revisions to small cell lung cancer (SCLC) with comparison to the current UICC 6th TNM Edition.
Ignatius Ou SH; Zell JA
J Thorac Oncol; 2009 Mar; 4(3):300-10. PubMed ID: 19156001
[TBL] [Abstract][Full Text] [Related]
44. Non-small cell lung cancer staging: proposed revisions to the TNM system.
Schneider BJ
Cancer Imaging; 2008 Sep; 8(1):181-5. PubMed ID: 18824424
[TBL] [Abstract][Full Text] [Related]
45. The IASLC Lung Cancer Staging Project: proposals for the inclusion of broncho-pulmonary carcinoid tumors in the forthcoming (seventh) edition of the TNM Classification for Lung Cancer.
Travis WD; Giroux DJ; Chansky K; Crowley J; Asamura H; Brambilla E; Jett J; Kennedy C; Rami-Porta R; Rusch VW; Goldstraw P;
J Thorac Oncol; 2008 Nov; 3(11):1213-23. PubMed ID: 18978555
[TBL] [Abstract][Full Text] [Related]
46. [The new TNM classification in lung cancer].
Wrona A; Jassem J
Pneumonol Alergol Pol; 2010; 78(6):407-17. PubMed ID: 21077033
[TBL] [Abstract][Full Text] [Related]
47. [New TNM classification of non-small cell lung cancer].
Chassagnon G; Bennani S; Revel MP
Rev Pneumol Clin; 2017 Feb; 73(1):34-39. PubMed ID: 28185685
[TBL] [Abstract][Full Text] [Related]
48. [Evolution and prognostic factors of adenocarcinomas of the prostate metastasizing at diagnosis].
Arrizabalaga Moreno M; García González JI; Mora Durvan M; Díez Rodríguez JM; Esteban Artiaga R; Navarro Sebastián J; Castro Pita M; Paniagua Andrés P
Actas Urol Esp; 1997 Sep; 21(8):724-36. PubMed ID: 9412221
[TBL] [Abstract][Full Text] [Related]
49. [Prognosis after complete surgical resection for non-small cell lung cancer based on the staging classification].
Pfannschmidt J; Muley T; Hoffmann H; Bülzebruck H; Dienemann H
Dtsch Med Wochenschr; 2006 Nov; 131(47):2643-8. PubMed ID: 17109272
[TBL] [Abstract][Full Text] [Related]
50. Surgery of primary lung cancer with oligometastatic m1b synchronous single brain metastasis: analysis of 37 cases.
Cheufou DH; Welter S; Chalvatzoulis E; Christof D; Theegarten D; Stamatis G
Thorac Cardiovasc Surg; 2014 Oct; 62(7):612-5. PubMed ID: 25136943
[TBL] [Abstract][Full Text] [Related]
51. Predictive factors for the development of brain metastasis in advanced unresectable metastatic melanoma.
Bedikian AY; Wei C; Detry M; Kim KB; Papadopoulos NE; Hwu WJ; Homsi J; Davies M; McIntyre S; Hwu P
Am J Clin Oncol; 2011 Dec; 34(6):603-10. PubMed ID: 21150567
[TBL] [Abstract][Full Text] [Related]
52. Validation of the 7th TNM classification for non-small cell lung cancer: a retrospective analysis on prognostic implications for operated node-negative cases.
Bergman P; Brodin D; Lewensohn R; de Petris L
Acta Oncol; 2013 Aug; 52(6):1189-94. PubMed ID: 23215828
[TBL] [Abstract][Full Text] [Related]
53. Capecitabine and cisplatin chemotherapy (XP) alone or sequentially combined chemoradiotherapy containing XP regimen in patients with three different settings of stage IV esophageal cancer.
Lee SS; Kim SB; Park SI; Kim YH; Ryu JS; Song HY; Shin JH; Jung HY; Lee GH; Choi KD; Cho KJ; Kim JH
Jpn J Clin Oncol; 2007 Nov; 37(11):829-35. PubMed ID: 17951334
[TBL] [Abstract][Full Text] [Related]
54. Prognostic impact of tumor size eliminating the ground glass opacity component: modified clinical T descriptors of the tumor, node, metastasis classification of lung cancer.
Nakamura S; Fukui T; Taniguchi T; Usami N; Kawaguchi K; Ishiguro F; Hirakawa A; Yokoi K
J Thorac Oncol; 2013 Dec; 8(12):1551-7. PubMed ID: 24389437
[TBL] [Abstract][Full Text] [Related]
55. The new tumor, node, and metastasis staging system.
Rami-Porta R; Bolejack V; Goldstraw P
Semin Respir Crit Care Med; 2011 Feb; 32(1):44-51. PubMed ID: 21500123
[TBL] [Abstract][Full Text] [Related]
56. Predicted outcomes of subdividing M1-stage metastatic lung cancer based on the prognosis and the response to local consolidative therapy.
Wang F; Gao J; Ren Y; Su H; She Y; Xie D; Chen C
Ann Transl Med; 2021 Aug; 9(16):1293. PubMed ID: 34532430
[TBL] [Abstract][Full Text] [Related]
57. TNM Staging of Non-Small Cell Lung Cancer: Comparison of PET/MR and PET/CT.
Huellner MW; de Galiza Barbosa F; Husmann L; Pietsch CM; Mader CE; Burger IA; Stolzmann P; Delso G; Frauenfelder T; von Schulthess GK; Veit-Haibach P
J Nucl Med; 2016 Jan; 57(1):21-6. PubMed ID: 26471696
[TBL] [Abstract][Full Text] [Related]
58. SEPAR guidelines for lung cancer staging.
Sánchez de Cos J; Hernández JH; López MF; Sánchez SP; Gratacós AR; Porta RR;
Arch Bronconeumol; 2011 Sep; 47(9):454-65. PubMed ID: 21824707
[TBL] [Abstract][Full Text] [Related]
59. Non-small cell lung cancer with ipsilateral pulmonary metastases: prognosis analysis and staging assessment.
Lee JG; Lee CY; Kim DJ; Chung KY; Park IK
Eur J Cardiothorac Surg; 2008 Mar; 33(3):480-4. PubMed ID: 18249000
[TBL] [Abstract][Full Text] [Related]
60. Impact of preoperative 18F-FDG PET/CT on survival of resected mono-metastatic non-small cell lung cancer.
Tönnies S; Tönnies M; Kollmeier J; Bauer TT; Förster GJ; Kaiser D; Wernecke KD; Pfannschmidt J
Lung Cancer; 2016 Mar; 93():28-34. PubMed ID: 26898611
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
